Compare ImmunityBio Inc. Common Stock (IBRX) vs Veeva Systems (VEEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Veeva Systems — how do they compare? ImmunityBio Inc. Common Stock trades at $9.99 (market cap $10.33B), while Veeva Systems trades at $285.41 (market cap $45.74B). The key difference: Veeva Systems is far larger — about 4.4× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is more actively traded (11,745,198 versus 1,118,315). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Veeva Systems for 5 Days on average.
| IBRX | VEEV | |
|---|---|---|
Market Cap | $10.33B | $45.74B |
Volume | 11,745,198 | 1,118,315 |
Sector | Health | Technology |
52-Week High | $11.55 | $299.10 |
52-Week Low | $1.98 | $151.43 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $10.79B | $38.65B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Veeva Systems
Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →
